1. Home
  2. Earnings Beat
  3. Compelling Reasons to Hold on to Cigna Stock for Now

Compelling Reasons to Hold on to Cigna Stock for Now


The Cigna Group (NYSE: CI) continues to be aided by two solid growth platforms, acquisitions and a solid financial position. A solid 2024 guidance also acts as an additional tailwind for the stock. 

Zacks Rank & Price Performance

Cigna carries a Zacks Rank #3 (Hold), at present.

The stock has gained 24% in the past year compared with the industry’s 8% growth. The Medical sector and the S&P 500 composite index have increased 4% and 23.2%, respectively, in the same time frame.

Zacks Investment Research
Image Source: Zacks Investment Research

Favorable Style Score

CI is well-poised for progress, as evidenced by its impressive VGM Score of A. Here, V stands for Value, G for Growth and M for Momentum, and the score is a weighted combination of all three factors.

Robust Growth Prospects

The Zacks Consensus Estimate for CI’s 2024 earnings is pegged at $28.47 per share, indicating an improvement of 13.5% from the year-earlier reading, while the same for revenues is $235.7 billion, implying a 20.7% increase from the prior-year actual.
The consensus mark for 2025 earnings is pegged at $31.97 per share, indicating 12.3% growth from the 2024 estimate. The same for revenues is $245.8 billion, which indicates a rise of 4.3% from the 2023 estimate.

Solid Surprise History

Cigna’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 3.29%.

Optimistic Outlook for 2024

This year, Cigna anticipates adjusted revenues to be a minimum of $235 billion, which indicates growth of at least 20.3% from the 2023 reported figure.

Adjusted …

Full story available on Benzinga.com

Visited 4 times, 1 visit(s) today